Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 967.8
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 08-Jul-2025
NAV [Rs.]
: 22.6615
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 1.55 | 3.32 | 12.01 | -3.4 | 9.96 | 22.41 | - | 12.21 |
| Category Avg | -0.14 | 1.64 | 17.63 | 6.34 | 4.87 | 20.58 | 21.81 | 15.89 |
| Category Best | 2.15 | 5.37 | 47.94 | 37.09 | 49.4 | 44.62 | 39.27 | 423.72 |
| Category Worst | -2.29 | -6.46 | 1.23 | -9.33 | -13.79 | 6.12 | 3.38 | -25.33 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 22.82 | 1335569 | 223.80 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 10.92 | 157270 | 107.09 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 10.70 | 696730 | 104.92 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 9.87 | 754236 | 96.79 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 5.92 | 299501 | 58.04 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 4.50 | 129528 | 44.14 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.01 | 346426 | 39.31 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 3.58 | 484784 | 35.13 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.36 | 66610 | 32.89 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.34 | 186536 | 32.71 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.31 | 139923 | 32.45 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 3.12 | 309305 | 30.61 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 2.70 | 745563 | 26.51 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.44 | 172138 | 23.92 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.35 | 6470 | 23.07 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.84 | 98580 | 18.07 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 1.72 | 100476 | 16.87 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.37 | 52143 | 13.42 |
| Equity | Natco Pharma | Pharmaceuticals & Biotechnology | 1.05 | 110995 | 10.28 |
| Equity | Granules India | Pharmaceuticals & Biotechnology | 0.91 | 179679 | 8.89 |
| Cash & Cash Equivalent | |||||
| Net CA & Others | Net CA & Others | -/- | 0.10 | 0 | 0.86 |
| Reverse Repo | TREPS | -/- | 0.07 | 0 | 0.66 |
| Cash & Cash Equivalent | C C I | -/- | 0.00 | 0 | 0.00 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,17,875.24
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
